Pall Corporation and RoosterBio, Inc. Announce Collaboration Agreement to Market Mesenchymal Stem/Stromal Cells and Bioreactor Expansion Systems

PORT WASHINGTON, N.Y.–(BUSINESS WIRE)– Pall Corporation, a global leader in bioprocess equipment and
disposables, announced the signing of a commercial collaboration
agreement with RoosterBio Inc., an innovative adult stem cell technology
company. The agreement will encompass a co-development and marketing
partnership, delivering complete solutions for industrial-scale
bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs).
These systems will enable the BioPharmaceutical industry to accelerate
product development, reduce clinical translation timelines and
ultimately streamline the commercialization pathway for stem cell-based
therapies.

Pall Life Sciences has continued expanding their Cell Therapy
Manufacturing solutions portfolio, and this partnership furthers that
aim. The complementary tools that RoosterBio and Pall contribute address
a major challenge and current bottleneck in the multi-billion dollar
Regenerative Medicine industry. Stem cell-based technologies are
progressing rapidly through the clinic, but manufacturing of cellular
therapeutics, including hMSCs, is significantly limited in scale. There
are few standards or complete solutions currently marketed that enable
simple, rapid development of scalable production methods of hMSCs. The
strategic alliance between Pall and RoosterBio will provide total
bioprocess solutions for cell culture of low cost, translation-friendly
hMSCs for development of Cell Therapy, Tissue Engineering, Drug
Screening, and Regenerative Medicine products.

Mario Philips, president, single-use technologies, stated, “Our vision
is aligned with the customer requirements of large scale stem cell
culture. Along with the RoosterBio hMSCs and media, the Pall solution
offerings such as XRS 20 and Xpansion multiplate bioreactors, SoloHill
microcarriers, and Allegro biocontainers enable our customers to grow
stem cells on an industrially relevant scale.”

Jon Rowley, RoosterBio’s Chief Executive & Technical Officer, states:
“Our mission at RoosterBio is to greatly increase the availability and
accessibility of stem cell technologies to researchers and product
developers across the globe. We are excited to be working with Pall and
their innovative technology team to develop complete solutions for the
simple and affordable generation of industrial quantities of hMSCs.
Pall’s global team will be critical in driving rapid adoption of these
systems on an international scale. This partnership will have a major
impact on the pace of the Regenerative Medicine field.”

About Pall Corporation

Pall Corporation is a filtration, separation and purification leader
providing solutions to meet the critical fluid management needs of
customers across the broad spectrum of life sciences and industrial
manufacturing. Pall works with customers to advance health, safety and
environmentally responsible technologies. The Company’s engineered
products enable process and product innovation and minimize emissions
and waste. Pall Corporation serves customers Worldwide. For more
information, please visit: www.pall.com,
or follow us on social media at: Facebook;
Google+;
LinkedIn;
Twitter;
and YouTube.

About RoosterBio

RoosterBio is a privately held biofabrication technology and products
company focused on accelerating the development of a sustainable
regenerative medicine industry, one customer at a time. RoosterBio has
simplified and standardized how stem cells are purchased, expanded, and
used in development, leading to marked time and costs savings for
customers. RoosterBio’s innovative products are ushering in a new era of
productivity and standardization into the field, where researchers spend
newly found time and money performing more high-value experiments,
accelerating the road to discovery in Regenerative Medicine. RoosterBio
serves customers Worldwide. For more information, please visit www.roosterbio.com,
or follow on twitter (@RoosterBio), or read the blog “Democratizing Cell
Technologies” (www.roosterbio.blogspot.com).

For more information, please contact us at: info@roosterbio.com

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005005744/en/